HDFC Pharma and Healthcare Fund - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 21.45 ↑ 0.87%
[as on 3 November, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 40 SMA
  • 500 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option and its peers as on 3 November, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option 24.85% 0.87% 3.47% 1.12% 0.88% 22.21% 29.08%---
SBI MNC FUND - REGULAR PLAN -GROWTH 10.97% 0.76% 2.91% -1.37% -4.37% 9.5% 6.24% 6.5% 11.65% 10.32%
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 21.07% 0.61% 3.01% 1.04% -0.98% 16.5% 23.22% 17.89% 23.4% 13.78%
SBI COMMA Fund - REGULAR PLAN - Growth 0.8% 0.52% 2.72% -0.7% -4.78% 1.88% 14.13% 9.06% 16.65% 13.73%
SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth -5.29% 1.31% 3.83% 3.85% -5.01% -4.45% 8.98% 6.45% 11.2% 11.03%
SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH -1.4% 0.59% 3.73% 2.11% -5.38% -2.2% 11.18% 14.06% 17.54% 14.3%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 50.48% 0.54%

Discrete returns (monthly)

MonthJan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026Oct 2026
Returns -4.75% 6.9% -4.45% 7.74% 5% 6.5% 3.5% 3.71% -2.19% 0.24%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 14.85%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.42% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.58%

Equity

NameSymbol / ISINSectorWeight %Other links
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology9.54%
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology8.94%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.08%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services4.06%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology4.04%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals & Biotechnology3.94%
Aster DM Quality Care LimitedASTERDM (INE914M01019)Healthcare Services3.84%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology3.70%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology3.48%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology3.24%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology3.23%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology3.10%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology3.06%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services2.85%
Rubicon Research LimitedRUBICON (INE506V01022)Pharmaceuticals & Biotechnology2.82%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services2.37%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology2.34%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services2.25%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.24%
Jupiter Life Line Hospitals Limited (INE682M01020)Healthcare Services1.94%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology1.93%
Dr Reddys Laboratories Ltd.DRREDDY (INE089A01031)Pharmaceuticals & Biotechnology1.90%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services1.90%
Molbio Diagnostics Limited (INE869T01028)Healthcare Equipment & Supplies1.77%
Biocon Ltd.BIOCON (INE376G01013)Pharmaceuticals & Biotechnology1.73%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.61%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.60%
Apollo Hospitals Enterprise Ltd.APOLLOHOSP (INE437A01024)Healthcare Services1.39%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.31%
SYMBIOTEC PHARMALAB LIMITED**** (INE899I01028)Pharmaceuticals & Biotechnology1.21%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology1.18%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.09%
CORONA REMEDIES LIMITEDCORONA (INE02ZQ01018)Pharmaceuticals & Biotechnology1.07%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology1.06%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology0.85%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology0.57%
Novartis India Ltd.NOVARTIND (INE234A01025)Pharmaceuticals & Biotechnology0.47%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.38%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology0.34%
Portfolio data is as on date 31 August, 2026

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
3 November, 202621.45 0.87%
2 November, 202621.264 0.45%
30 October, 202621.169 0.41%
29 October, 202621.083 0.67%
28 October, 202620.942 1.02%
27 October, 202620.731 2.17%
26 October, 202620.291 1.85%
23 October, 202619.923 -0.68%
22 October, 202620.06 -0.11%
21 October, 202620.082 -0.66%
19 October, 202620.215 -1.3%
16 October, 202620.481 0.02%
15 October, 202620.476 -0.24%
14 October, 202620.526 -1.04%
13 October, 202620.742 -0.16%
12 October, 202620.775 -0.14%
9 October, 202620.805 0.77%
8 October, 202620.646 -2.38%
7 October, 202621.149 -0.33%
6 October, 202621.219 0.97%
5 October, 202621.016 -0.93%
1 October, 202621.213 0.15%
30 September, 202621.181 -2%
29 September, 202621.613 0.34%
28 September, 202621.54 -1.31%
25 September, 202621.826 -0.41%
24 September, 202621.916 -0.75%
23 September, 202622.081 0.81%
22 September, 202621.904 -0.89%
21 September, 202622.101

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option is 21.45 as on 3 November, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option are 24.85% as on 3 November, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option are 22.21% as on 3 November, 2026.
  • What are 3 year CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option?
    The 3 year annualized returns (CAGR) of HDFC Pharma and Healthcare Fund - Growth Option are 29.08% as on 3 November, 2026.
  • What are top 10 holdings of HDFC Pharma and Healthcare Fund - Growth Option?
    Top 10 holdings of HDFC Pharma and Healthcare Fund - Growth Option are:
    • Divis Laboratories Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Torrent Pharmaceuticals Ltd.
    • Max Healthcare Institute Limited
    • Lupin Ltd.
    • Cipla Ltd.
    • Aster DM Quality Care Limited
    • Neuland Laboratories Limited
    • Anthem Biosciences Limited
    • Acutaas Chemicals Limited
    • Ipca Laboratories Ltd.
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for HDFC Pharma and Healthcare Fund - Growth Option?
    HDFC Pharma and Healthcare Fund - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.